The share price has tracked EPS growth, suggesting market sentiment towards the shares remains steady. The stock's recent performance has improved, with a better one-year total shareholder return than the five-year return. Dividends have enhanced the total shareholder return.
CSL anticipates robust annualized double-digit earnings growth over the medium term, driven by strong patient demand for its immunoglobulins franchise. The company has bounced back from the pandemic's impact on its blood plasma collections.
The positive trends in Carlisle Companies' ROCE and its ability to consistently reinvest in itself make it an attractive investment. Investors are expecting more growth in the future. However, it's important to check if these trends will continue.
The stock is seen as overpriced by valuation models, making it less attractive for purchase. With the company's low likelihood of significant earnings growth, its investment appeal is diminished. Profits could be made if share prices meet realistic values.
Carlisle Companies' growth is praised, but future performance remains key. Dividends have boosted total shareholder return, despite short-term performance being below market. Effective business strategy is expected to continue but investors should note identified risks.
Despite no insider trades recently at Carlisle Companies, management's considerable stock ownership aligns their interests with shareholders'. Yet, no insider buying in the last year is concerning.
This downgrade hints at a downturn in business conditions for Carlisle Companies, suggesting worse than industry performance and potential market caution. The downgrade may increase the company's debt pressure, hinting at possible fiscal tightening.
卡莱尔伙伴股票讨论区
专栏US Top Gap Ups and Downs on 10/28: PINS, TMUS, AMZN, JD and More
Gap Ups
1. $德康医疗(DXCM.US)$ - up 6.43%
2. $艾奇资本(ACGL.US)$ - up 6.26%
3. $Pinterest(PINS.US)$ - up 5.32%
4. $吉利德科学(GILD.US)$ - up 3.83%
5. $威瑞信(VRSN.US)$ - up 3.65%
6. $T-Mobile US(TMUS.US)$ - up 3.05%
7. $亚瑟加拉格尔(AJG.US)$ - up 2.11%
8. $nVent Electric(NVT.US)$ - 2.09%...
卡莱尔伙伴(CSL) 是1960年上市的美国公司,2002年到现在,股价从13.5上升到288,考虑到期间还做过一次1拆2,20年平均回报率20.6%,非常了得。
5年来毛利率在28%上下,净资产收益率一度冲上23.8%,大部分时间都在18%以下,2021年为16.3%,没有特别吸引人。
5年来营收从41亿上升到48亿,其中2020年下滑了11.8%;营业利润在2019年到达高点,2020年下滑26%,2021年反弹17.4%;净利润在2018年达到高点,应该是有主营业务以外的收入,2019年恢复正常,2020年下滑32.3%,2021年又反弹了31.7%,5年总体还是提升的。
2022前两季度营收、营业利润和净利润分别暴增58%,215%,227%。
利润表显示2018年有2.5亿的停止经营利润,如果不考虑这部分,2018年净利润也是下滑的。5年来公司的利息费用不降反升,说明对借贷的依赖没有减少。
资产负债表5年来从52.3%上升到了62%,主要是长期借款增加很快。另外2021年商誉及其他无形资产增加了15亿,应该是有大笔收购...
专栏Top upgrades and downgrades on 4/5
• $Clean Harbors(CLH.US)$ : Goldman Sachs Upgrades to Neutral from Sell - PT $120
• $艾茨克普(EZPW.US)$ : Jefferies Upgrades to Buy From Hold - PT $8.50
• $First Republic Bank(FRC.US)$ : Credit Suisse Upgrades to Neutral From Underperform - PT $187
• $Generac(GNRC.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $410
• $梯瓦制药(TEVA.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $13 (from $11)
• $赛莱默(XYL.US)$ ...
暂无评论